Decision

URL: https://democracy.camden.gov.uk/ieDecisionDetails.aspx?ID=4548

Decision Maker: Director of Health and Wellbeing

Outcome: Recommendations Approved

Is Key Decision?: No

Is Callable In?: No

Purpose: This report seeks approval of a variation to the contract for Camden’s Adult Substance Misuse Treatment and Recovery Service. The contract was awarded in November 2022 to Change Grow Live (CGL) Services Ltd and began on 1st April 2023.   Savings generated by the contract value awarded to Change, Grow, Live (CGL) to deliver Camden’s Integrated Drug and Alcohol Service has resulted in a £500,000 underspend across the Health and Wellbeing Drug and Alcohol Cost Centres.  According to the requirements of the Supplementary Substance Misuse Treatment and Recovery Grant, local authorities must demonstrate that substance misuse budgets from the Public Health Grant are fully spent on drug/alcohol related interventions.  Therefore, any underspend generated in this cost centre must be reinvested in substance misuse services.   Earlier this year officers awarded CGL £3,200 for a six-month pilot which required CGL to deliver fortnightly clinical supervision to FWD (Camden’s young people’s drug and alcohol service). Initial evaluation of the pilot has identified that FWD staff value the supervision sessions and has led to improvements in their case work with young people who present with multiple/complex needs.  As a result, officers would like to make this arrangement permanent for the remainder of the CGL contract period.   This report seeks approval to allocate a further £5,000 to CGL for the remainder of this financial year, and £10,000 for the remaining four years of the initial contract period (£45,000 in total).  This will fund Clinicians from CGL who will provide FWD with support in managing substance misuse (drugs and alcohol) related issues amongst their caseload. The variation will end on 31 March 2029.   This report is being presented to Director of Health and Wellbeing for approval in line with Contract Standing Order E1.   

Content: This report seeks approval of a variation to the contract for Camden’s Adult Substance Misuse Treatment and Recovery Service. The contract was awarded in November 2022 to Change Grow Live (CGL) Services Ltd and began on 1st April 2023.   Savings generated by the contract value awarded to Change, Grow, Live (CGL) to deliver Camden’s Integrated Drug and Alcohol Service has resulted in a £500,000 underspend across the Health and Wellbeing Drug and Alcohol Cost Centres.  According to the requirements of the Supplementary Substance Misuse Treatment and Recovery Grant, local authorities must demonstrate that substance misuse budgets from the Public Health Grant are fully spent on drug/alcohol related interventions.  Therefore, any underspend generated in this cost centre must be reinvested in substance misuse services.   Earlier this year officers awarded CGL £3,200 for a six-month pilot which required CGL to deliver fortnightly clinical supervision to FWD (Camden’s young people’s drug and alcohol service). Initial evaluation of the pilot has identified that FWD staff value the supervision sessions and has led to improvements in their case work with young people who present with multiple/complex needs.  As a result, officers would like to make this arrangement permanent for the remainder of the CGL contract period.   This report seeks approval to allocate a further £5,000 to CGL for the remainder of this financial year, and £10,000 for the remaining four years of the initial contract period (£45,000 in total).  This will fund Clinicians from CGL who will provide FWD with support in managing substance misuse (drugs and alcohol) related issues amongst their caseload. The variation will end on 31 March 2029.   This report is being presented to Director of Health and Wellbeing for approval in line with Contract Standing Order E1.    THAT the Director of Health and Wellbeing approves the variation of the contract with Change Grow Live Services Ltd to reflect a further increase in the contract price for 2024/25 by £5,000, and then £10,000 for 2025/26, 2026/27, 2037/28 and 2028/29.

Date of Decision: December 19, 2024